Cappello Joseph
CIK 0001939198
VP, Pharmaceutical Development
Filings
13
Latest May 12, 2026
Issuers covered
1
Showing
13 of 13
Page 1
Track record
7 of 8 open-market trades scored (88% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 43% | -2.9% | -4.1% | +21.0% | -19.5% |
| 90 days | 6 | 33% | -11.7% | -31.7% | +51.2% | -58.1% |
| 180 days | 6 | 67% | +2.4% | +25.6% | +66.2% | -111.9% |
| 365 days | 3 | 33% | +3.6% | -6.8% | +91.3% | -73.7% |
Issuers
Companies where Cappello Joseph has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GNLX | Genelux Corp | 13 | May 12, 2026 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|